» Articles » PMID: 35742836

Serum-Free Cultures: Could They Be a Future Direction to Improve Neuronal Differentiation of Mesenchymal Stromal Cells?

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jun 24
PMID 35742836
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem/stromal cells (MSCs) are undifferentiated cells with multilinear potential, known for their immunomodulatory and regenerative properties. Although the scientific community is working to improve their application, concerns limit their use to repair tissues following neurological damage. One of these obstacles is represented by the use of culture media supplemented with fetal bovine serum (FBS), which, due to its xenogenic nature and the risk of contamination, has increased scientific, ethical and safety problems. Therefore, the use of serum-free media could improve MSC culture methods, avoiding infectious and immunogenic transmission problems as well as MSC bioprocesses, without the use of animal components. The purpose of our review is to provide an overview of experimental studies that demonstrate that serum-free cultures, along with the supplementation of growth factors or chemicals, can lead to a more defined and controlled environment, enhancing the proliferation and neuronal differentiation of MSCs.

Citing Articles

Comparative Analysis of Serum and Serum-Free Medium Cultured Mesenchymal Stromal Cells for Cartilage Repair.

Kang M, Yang Y, Zhang H, Zhang Y, Wu Y, Denslin V Int J Mol Sci. 2024; 25(19).

PMID: 39408956 PMC: 11476526. DOI: 10.3390/ijms251910627.


Development of scaffold-free tissue-engineered constructs derived from mesenchymal stem cells with serum-free media for cartilage repair and long-term preservation.

Maeda S, Matsumoto M, Segawa K, Iwamoto K, Nakamura N Cytotechnology. 2024; 76(5):595-612.

PMID: 39188648 PMC: 11344744. DOI: 10.1007/s10616-024-00637-y.


Spheroid trilineage differentiation model of primary mesenchymal stem/stromal cells under hypoxia and serum-free culture conditions.

Moldaschl J, Chariyev-Prinz F, Toegel S, Keck M, Hiden U, Egger D Front Bioeng Biotechnol. 2024; 12:1444363.

PMID: 39144480 PMC: 11321963. DOI: 10.3389/fbioe.2024.1444363.


Bone Regeneration with Mesenchymal Stem Cells in Scaffolds: Systematic Review of Human Clinical Trials.

Theodosaki A, Tzemi M, Galanis N, Bakopoulou A, Kotsiomiti E, Aggelidou E Stem Cell Rev Rep. 2024; 20(4):938-966.

PMID: 38407793 PMC: 11087324. DOI: 10.1007/s12015-024-10696-5.


Effect assessment of a type of xeno-free and serum-free human adipose-derived mesenchymal stem cells culture medium by proliferation and differentiation capacities.

Chen S, Meng L, Wang S, Xu Y, Chen W, Wei J Cytotechnology. 2023; 75(5):403-420.

PMID: 37655274 PMC: 10465441. DOI: 10.1007/s10616-023-00586-y.


References
1.
Koc O, Day J, Nieder M, Gerson S, Lazarus H, Krivit W . Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002; 30(4):215-22. DOI: 10.1038/sj.bmt.1703650. View

2.
Longobardi L, ORear L, Aakula S, Johnstone B, Shimer K, Chytil A . Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res. 2006; 21(4):626-36. DOI: 10.1359/jbmr.051213. View

3.
Suon S, Jin H, Donaldson A, Caterson E, Tuan R, Deschennes G . Transient differentiation of adult human bone marrow cells into neuron-like cells in culture: development of morphological and biochemical traits is mediated by different molecular mechanisms. Stem Cells Dev. 2005; 13(6):625-35. PMC: 1976185. DOI: 10.1089/scd.2004.13.625. View

4.
Gronthos S, Brahim J, Li W, Fisher L, Cherman N, Boyde A . Stem cell properties of human dental pulp stem cells. J Dent Res. 2002; 81(8):531-5. DOI: 10.1177/154405910208100806. View

5.
Taha M, Javeri A, Kheirkhah O, Majidizadeh T, Khalatbary A . Neural differentiation of mouse embryonic and mesenchymal stem cells in a simple medium containing synthetic serum replacement. J Biotechnol. 2013; 172:1-10. DOI: 10.1016/j.jbiotec.2013.11.028. View